New York State Teachers Retirement System raised its stake in Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 2.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 72,294 shares of the company’s stock after buying an additional 1,388 shares during the quarter. New York State Teachers Retirement System owned about 0.16% of Avanos Medical worth $1,737,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. BNP Paribas Financial Markets grew its stake in shares of Avanos Medical by 314.4% in the first quarter. BNP Paribas Financial Markets now owns 53,583 shares of the company’s stock worth $1,067,000 after acquiring an additional 40,653 shares in the last quarter. Janney Montgomery Scott LLC grew its stake in Avanos Medical by 19.1% during the 1st quarter. Janney Montgomery Scott LLC now owns 13,010 shares of the company’s stock worth $259,000 after purchasing an additional 2,082 shares in the last quarter. Empowered Funds LLC increased its holdings in Avanos Medical by 8.2% during the 1st quarter. Empowered Funds LLC now owns 177,554 shares of the company’s stock worth $3,535,000 after purchasing an additional 13,409 shares during the period. William Blair Investment Management LLC raised its position in Avanos Medical by 16.8% in the 1st quarter. William Blair Investment Management LLC now owns 1,425,036 shares of the company’s stock valued at $28,372,000 after purchasing an additional 204,826 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System boosted its stake in shares of Avanos Medical by 8.6% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 19,053 shares of the company’s stock valued at $379,000 after buying an additional 1,516 shares during the period. Institutional investors and hedge funds own 95.17% of the company’s stock.
Avanos Medical Price Performance
AVNS stock opened at $20.41 on Friday. The firm has a 50 day moving average of $22.75 and a 200-day moving average of $21.53. The company has a market cap of $938.04 million, a price-to-earnings ratio of 60.03 and a beta of 0.92. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12. Avanos Medical, Inc. has a 12-month low of $17.39 and a 12-month high of $25.36.
Analysts Set New Price Targets
View Our Latest Research Report on AVNS
Avanos Medical Company Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Stories
- Five stocks we like better than Avanos Medical
- Top Stocks Investing in 5G Technology
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- What is MarketRank™? How to Use it
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- How to Use the MarketBeat Dividend Calculator
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS – Free Report).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.